期刊文献+

登革病毒共有抗原片段的筛选与鉴定

SELECTION AND PRIMARY DISTINGUISHING OF ONE FRAGMENT OF DENGUE VIRUS SHARED ANTIGEN SEQUENCE
下载PDF
导出
摘要 目的经生物信息学分析及实验验证,筛选登革病毒共有的特异性抗原片段,为其免疫学诊断试剂的研制奠定基础。方法参考亲水性、抗原性、可塑性、表面可及性及二级结构信息,对登革病毒1-4型可能共有的特异性抗原表位进行系统的预测分析,分析其在不同毒株中的保守性,并对部分抗原表位进行高效原核表达,采用Western blot验证其反应原性。结果利用pET32a原核表达系统对6种病毒(登革1-4型病毒、流行性乙型脑炎病毒、黄热病毒)部分可能的抗原片段进行了高效表达;经Western blot筛选,获得一段登革1-4型病毒共有抗原片段DV1-2,与实验中所用其它黄病毒属及甲病毒属多克隆抗体无明显的交叉反应。结论 DV1-2为登革1-4型病毒共有的特异性抗原片段,可用于其免疫学诊断试剂的研制。 Objective To analyse the protein epitopes of dengue virus type 1-4,and to distinguish the shared specific epitopes,so as to provide the basis for developing immunological diagnostic reagents.Methods Bioinformatic software DNAstar was used to analyze the hydrophilicity,flexibility,surface probability and antigenicity of dengue virus type 1-4 protein amino acid sequence and also the influence of secondary structure.Based on the bioinformatic analysis,6 specific epitopes were amplified and inserted into prokaryotic expression vector pET32a.Then the vectors were transferred into Rosetta(DE3).Isopropyl-β-D-thiogalactoside(IPTG) was used to induce the expression of gene segments.SDS-PAGE were used to identify the expression of proteins.Then the antigenicity was tested using Western blot.Results Six epitopes from Dengue virus type 1-4,Japanese encephalitis virus,and yellow fever virus were expressed in E.coli,respectively.One dengue virus shared antigenic fragment(DV1-2) from dengue virus type 1 was confirmed using Western blot.And there was no obvious cross reaction of DV1-2 with Japanese encephalitis virus,yellow fever virus,Chikungunya virus(CHIKV) and sindbis virus(SINV) polyclonal antibody.Conclusion Fragment DV1-2 showed a good reactogenicity,and can be used to develop immunological diagnostic reagents.
出处 《解放军预防医学杂志》 CAS 2012年第5期321-324,共4页 Journal of Preventive Medicine of Chinese People's Liberation Army
基金 广东省科技计划项目(No.2010B031600125 2011B031500011) 广州市科技计划项目(No.10C36091668)
关键词 登革病毒 抗原表位 原核表达 dengue virus antigen epitope prokaryotic expression
  • 相关文献

参考文献9

  • 1GUILARDE A 0,TURCHI M D, SIQUEURA J B Jr, etal. Dengue and dengue hemorrhagic fever among adults :clinical outcomes related to viremia, serotypes, and anti-body response[J]. J Infect Dis, 2008,197(6) : 817.
  • 2KYTE J, DOOLITTLE R F. A simple method for displa-ying the hydropathic character of a protein[J]. Journal ofMolecular Biology, 1982,157( 1 ) :105.
  • 3JAMESON B A, WOLF H. The antigenic index: a novelalgorithm for predicting antigenic determinants( J]. Com-puter Applications in the Biosciences, 1988,4(1) :181.
  • 4KARPLUS P A,SCHULTZ G E. Prediction of chain flexi-bility in proteins[J]. Immunology, 1985,72(2) ; 212.
  • 5EMINI E A,HUGHES J’ PERLOW al. Induction of hep-atitis A virus- neutralizing antibody by a virus-specific syn-thetic peptidefj]. Journal of Virology, 1985,55(3) :836.
  • 6徐晓立,杨建军,任瑞文,刘建伟,马四辈,白志军,方美玉.主要黄病毒E蛋白抗原表位分析与初步鉴定[J].中华流行病学杂志,2009,30(5):489-492. 被引量:2
  • 7OSAH 0 P, SUBEDI S, MORITA K,et al Serologicalstudy of dengue virus infection in Terai region, Nepal[J]. Nepal Med Coll J,2009, 11(2) :104.
  • 8BROWN M G, VICKERS I E, SALAS R A, et al. Sero-prevalence of dengue virus antibodies in healthy Jamai-cans [J] . Hum Antibodies,2009, 18(4) : 123.
  • 9SHU P Y,CHEN L K,CHANG S F,et al. Dengue vims se-rotyping based on envelope/membrane ( E/M ) and non-structural protein NS1 serotype-specific capture immuno-globulin M (IgM) enzyme-linked immunosorbent assays(EUSA)[J] _ J Clin Microbiol,2004,42(6) :2489.

二级参考文献14

  • 1Falcioni F, Ito K, Vidovic D, et al. Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease- associated class Ⅱ major histocompatibility molecules. Nat Biotechnol, 1999,17: 562.
  • 2John TR, Richard A, Bolin RG, et al. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus. Jamaica, 1998, 246(2) : 317-328.
  • 3Wu S J, Grouard V, Sun W, et al. Human skin Langerhans cells are targets of dengue virus infection. Nature Med, 2000, 6 (7) : 816-820.
  • 4Thaweesak T, Bala C, Robert P, et al. Mapping of a region of dengue virus type-2 glycoprotein required for binding by a neutralizing monoclonal antibody. Gene, 1992, 2 ( 15 ) : 135-190.
  • 5Guilarde AO, Turchi MD, Jr JB, et al. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response. J Infect Dis, 2008, 197(6) :817-824.
  • 6Beaumier CM, Mathew A, Bashyam HS, et al. Cross-reactive memory CD8 ( + ) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner. J Infect Dis, 2008, 197(4) :608-617.
  • 7Lazaro-Olan L, Mellado-Sanchez G, Garcia-Cordero J, et al. Analysis of antibody response in human dengue patients from the mexican coast using recombinant antigens. Vector Borne Zoonotic Dis, 2008, 8( 1 ) : 69-80.
  • 8De Paula SO, Fonseca BA. Dengue: a review of the laboratory tests a clinician must know to achieve a correct diagnosis. Braz J Infect Dis, 2004, 8(6) : 390-398.
  • 9Kyte J, Doolittle RF. A simple method for displaying hydrophablic character of a protein. J Mol Biol, 1983, 157( 1 ) : 105-132.
  • 10Jameson BA, Wolf H. The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci, 1988, 4 (1):181-186,

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部